BCR signaling in ABC- DLBCL highly depends on the NF-κB pathway-mediated anti-apoptotic events that are conciliated by CARMA1 mutations and loss of function mutations of modulators turning down NF-κB [41]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.